IDEAS home Printed from https://ideas.repec.org/a/bpj/fhecpo/v16y2013i2p121-133n6.html
   My bibliography  Save this article

The Value of Diagnostic Testing in Personalized Medicine

Author

Listed:
  • Goldman Dana P.
  • Lakdawalla Darius
  • Sood Neeraj

    (Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, CA, USA)

  • Gupta Charu
  • Vasudeva Eshan

    (Precision Health Economics, Los Angeles, CA, USA)

  • Trakas Kostas
  • Riley Ralph

    (Janssen Diagnostics, Toronto, ON, Canada and Philadelphia, PA, USA)

  • Agus David

    (Center for Applied Molecular Medicine, University of Southern California, Los Angeles, CA, USA)

  • Jena Anupam B.

    (Harvard Medical School and Massachusetts General Hospital, Boston, MA, USA)

  • Philipson Tomas J.

    () (Harris School of Public Policy, The University of Chicago, 1155 East 60th Street, Chicago, IL 60637, USA)

Abstract

Personalized medicine – the targeting of therapies to individuals on the basis of their biological, clinical, or genetic characteristics – is thought to have the potential to transform health care. While much emphasis has been placed on the value of personalized therapies, less attention has been paid to the value generated by the diagnostic tests that direct patients to those targeted treatments. This paper presents a framework derived from information economics for assessing the value of diagnostics. We demonstrate, via a case study, that the social value of such diagnostics can be very large, both by avoiding unnecessary treatment and by identifying patients who otherwise would not get treated. Despite the potential social benefits, diagnostic development has been discouraged by cost-based, rather than value-based, reimbursement.

Suggested Citation

  • Goldman Dana P. & Lakdawalla Darius & Sood Neeraj & Gupta Charu & Vasudeva Eshan & Trakas Kostas & Riley Ralph & Agus David & Jena Anupam B. & Philipson Tomas J., 2013. "The Value of Diagnostic Testing in Personalized Medicine," Forum for Health Economics & Policy, De Gruyter, vol. 16(2), pages 121-133, September.
  • Handle: RePEc:bpj:fhecpo:v:16:y:2013:i:2:p:121-133:n:6
    as

    Download full text from publisher

    File URL: https://www.degruyter.com/view/j/fhep.2013.16.issue-2/fhep-2013-0023/fhep-2013-0023.xml?format=INT
    Download Restriction: For access to full text, subscription to the journal or payment for the individual article is required.

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Philipson Tomas J & Jena Anupam B, 2006. "Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs," Forum for Health Economics & Policy, De Gruyter, vol. 9(2), pages 1-33, January.
    2. Nelson, Phillip, 1970. "Information and Consumer Behavior," Journal of Political Economy, University of Chicago Press, vol. 78(2), pages 311-329, March-Apr.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. repec:nbr:nberch:13986 is not listed on IDEAS
    2. Manuel I. Hermosilla & Jorge A. Lemus, 2017. "Therapeutic Translation of Genomic Science: Opportunities and limitations of GWAS," NBER Working Papers 23989, National Bureau of Economic Research, Inc.
    3. repec:nbr:nberch:13988 is not listed on IDEAS

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bpj:fhecpo:v:16:y:2013:i:2:p:121-133:n:6. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Peter Golla). General contact details of provider: https://www.degruyter.com .

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service hosted by the Research Division of the Federal Reserve Bank of St. Louis . RePEc uses bibliographic data supplied by the respective publishers.